Emory's Psychedelic Challenges project: speaking nuance to hype
A mounting base of evidence speaks to the potential psychological and spiritual benefits of psilocybin mushrooms and other psychedelics. However, for honest researchers, clinicians, and community leaders, listening carefully to people's stories of post-psychedelic harms and difficulties is an equally important task. In this talk, we present insights and reflections from this line of study.

Josh Lipson, PhD, is a postdoctoral research fellow at the Emory Center for Psychedelics and Spirituality, and a graduate of Columbia University’s clinical psychology doctoral program. His dissertation research focused on psychosocial, spiritual, and mood-related predictors of psychedelic experiences and their downstream effects, and he currently helps to lead ECPS' Psychedelic Challenges study. Over the last several years, he has clinically trained in a range of both acute and long-term inpatient psychiatric settings in New York City. He brings perspectives from both these threads of experience to the study of post-psychedelic challenges and adverse effects.